Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
35.03
+0.01 (0.03%)
Jun 3, 2025, 1:15 PM - Market open
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.52 billion as of June 3, 2025. Its market cap has decreased by -42.01% in one year.
Market Cap
4.52B
Enterprise Value
2.97B
1-Year Change
-42.01%
Ranking
Category
Stock Price
$35.03
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.52B, an increase of 227.47%. That is a compound annual growth rate of 26.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 4.52B | -55.72% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |